MATRICS MCCB

Calibration and cross-validation of MCCB and CogState in schizophrenia

Authors: Jane Lees, Eve Applegate, Richard Emsley, Shôn Lewis, Panayiota Michalopoulou, Tracey Collier, Cristina Lopez-Lopez, Shitij Kapur, Gahan J Pandina, Richard J Drake

Journal: Psychopharmacology

Year Published: 2015

Rationale: Cognitive impairment associated with schizophrenia is a key predictor of functional outcomes. The FDA-accepted MATRICS Consensus Cognitive Battery (MCCB) is held to be the gold standard measure but there are concerns about its ease of […]

Back to Publications

Cogstate
© 2024 Cogstate Ltd.

Cogstate acknowledges Aboriginal and Torres Strait Islander people as the Traditional Custodians of the lands where many of our team members live and work. We pay respect to their Elders past and present.